# Graftech International Ltd: financial statements, quarterly

EAF · NYSE · CIK 931148 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/eaf.md) · [Financials](/companies/eaf/financials.md) · [Filings](/companies/eaf/filings.md) · [Insiders](/companies/eaf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/eaf/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [137 d](/filings/0000931148-26-000017.md) | [137](/filings/0000931148-25-000073.md) | [137](/filings/0000931148-25-000117.md) | [131](/filings/0000931148-25-000156.md) | [134 d](/filings/0000931148-26-000017.md) | [112](/filings/0000931148-26-000051.md) | [132](/filings/0000931148-26-000073.md) | [144](/filings/0000931148-26-000087.md) | [116 d](/filings/0000931148-26-000017.md) | [125](/filings/0000931148-26-000051.md) | [127](/filings/0000931148-26-000073.md) | [140](/filings/0000931148-26-000087.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | [(19.7) d](/filings/0000931148-26-000017.md) | [(1.3)](/filings/0000931148-25-000073.md) | [4.0](/filings/0000931148-25-000117.md) | [(12.1)](/filings/0000931148-25-000156.md) | [(10.4) d](/filings/0000931148-26-000017.md) | [(1.7)](/filings/0000931148-26-000051.md) | [0.1](/filings/0000931148-26-000073.md) | [10.3](/filings/0000931148-26-000087.md) | [(24.3) d](/filings/0000931148-26-000017.md) | [(15.0)](/filings/0000931148-26-000051.md) | [(0.4)](/filings/0000931148-26-000073.md) | [5.6](/filings/0000931148-26-000087.md) |
| Research and development | $m | [1.8 d](/filings/0000931148-26-000017.md) | [1.6](/filings/0000931148-25-000073.md) | [1.4](/filings/0000931148-25-000117.md) | [1.2](/filings/0000931148-25-000156.md) | [1.4 d](/filings/0000931148-26-000017.md) | [1.9](/filings/0000931148-26-000051.md) | [1.3](/filings/0000931148-26-000073.md) | [1.6](/filings/0000931148-26-000087.md) | [1.6 d](/filings/0000931148-26-000017.md) | [1.4](/filings/0000931148-26-000051.md) | [1.5](/filings/0000931148-26-000073.md) | [1.5](/filings/0000931148-26-000087.md) |
| Selling, general and administrative | $m | [15.1 d](/filings/0000931148-26-000017.md) | [15.3](/filings/0000931148-25-000073.md) | [5.1](/filings/0000931148-25-000117.md) | [13.1](/filings/0000931148-25-000156.md) | [13.1 d](/filings/0000931148-26-000017.md) | [14.6](/filings/0000931148-26-000051.md) | [13.3](/filings/0000931148-26-000073.md) | [13.8](/filings/0000931148-26-000087.md) | [13.2 d](/filings/0000931148-26-000017.md) | [14.2](/filings/0000931148-26-000051.md) | [12.6](/filings/0000931148-26-000073.md) | [13.0](/filings/0000931148-26-000087.md) |
| Operating income | $m | [(208) d](/filings/0000931148-26-000017.md) | [(21.4)](/filings/0000931148-25-000073.md) | [(2.7)](/filings/0000931148-25-000117.md) | [(26.3)](/filings/0000931148-25-000156.md) | [(24.9) d](/filings/0000931148-26-000017.md) | [(18.2)](/filings/0000931148-26-000051.md) | [(14.6)](/filings/0000931148-26-000073.md) | [(5.1)](/filings/0000931148-26-000087.md) | [(39.2) d](/filings/0000931148-26-000017.md) | [(30.7)](/filings/0000931148-26-000051.md) | [(14.6)](/filings/0000931148-26-000073.md) | [(22.7)](/filings/0000931148-26-000087.md) |
| Interest expense | $m | [15.7 d](/filings/0000931148-26-000017.md) | [15.6](/filings/0000931148-25-000073.md) | [15.6](/filings/0000931148-25-000117.md) | [16.5](/filings/0000931148-25-000156.md) | [37.6 d](/filings/0000931148-26-000017.md) | [29.8](/filings/0000931148-26-000051.md) | [25.4](/filings/0000931148-26-000073.md) | [24.5](/filings/0000931148-26-000087.md) | [24.3 d](/filings/0000931148-26-000017.md) | [24.2](/filings/0000931148-26-000051.md) | [24.4](/filings/0000931148-26-000073.md) | [25.9](/filings/0000931148-26-000087.md) |
| Income tax | $m | [(7.7) d](/filings/0000931148-26-000017.md) | [(4.2)](/filings/0000931148-25-000073.md) | [(0.6)](/filings/0000931148-25-000117.md) | [(5.3)](/filings/0000931148-25-000156.md) | [(12.0) d](/filings/0000931148-26-000017.md) | [(7.2)](/filings/0000931148-26-000051.md) | [51.2](/filings/0000931148-26-000073.md) | [0.1](/filings/0000931148-26-000087.md) | [5.3 d](/filings/0000931148-26-000017.md) | [1.3](/filings/0000931148-26-000051.md) | [1.7](/filings/0000931148-26-000073.md) | [0.1](/filings/0000931148-26-000087.md) |
| Net income | $m | [0.0 d](/filings/0000931148-26-000017.md) | [(30.9)](/filings/0000931148-25-000156.md) | [(14.8)](/filings/0000931148-25-000156.md) | [(36.1)](/filings/0000931148-25-000156.md) | [(49.5) d](/filings/0000931148-26-000017.md) | [(39.4)](/filings/0000931148-26-000087.md) | [(86.9)](/filings/0000931148-26-000087.md) | [(28.5)](/filings/0000931148-26-000087.md) | [(65.1) d](/filings/0000931148-26-000017.md) | [(43.3)](/filings/0000931148-26-000087.md) | [(40.5)](/filings/0000931148-26-000087.md) | [(46.8)](/filings/0000931148-26-000087.md) |
| Diluted EPS | $ per share | not reported | [(0.12)](/filings/0000931148-25-000073.md) | [(0.06)](/filings/0000931148-25-000117.md) | [(1.40)](/filings/0000931148-25-000156.md) | not reported | [(1.52)](/filings/0000931148-26-000051.md) | [(3.35)](/filings/0000931148-26-000073.md) | [(1.10)](/filings/0000931148-26-000087.md) | not reported | [(1.66)](/filings/0000931148-26-000051.md) | [(1.54)](/filings/0000931148-26-000073.md) | [(1.76)](/filings/0000931148-26-000087.md) |
| Basic EPS | $ per share | not reported | [(0.12)](/filings/0000931148-25-000073.md) | [(0.06)](/filings/0000931148-25-000117.md) | [(1.40)](/filings/0000931148-25-000156.md) | not reported | [(1.52)](/filings/0000931148-26-000051.md) | [(3.35)](/filings/0000931148-26-000073.md) | [(1.10)](/filings/0000931148-26-000087.md) | not reported | [(1.66)](/filings/0000931148-26-000051.md) | [(1.54)](/filings/0000931148-26-000073.md) | [(1.76)](/filings/0000931148-26-000087.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [177](/filings/0000931148-24-000101.md) | [165](/filings/0000931148-24-000065.md) | [121](/filings/0000931148-24-000101.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $m | [675](/filings/0000931148-25-000028.md) | [620](/filings/0000931148-24-000065.md) | [583](/filings/0000931148-24-000101.md) | [558](/filings/0000931148-24-000121.md) | [637](/filings/0000931148-26-000017.md) | [619](/filings/0000931148-25-000073.md) | [566](/filings/0000931148-25-000117.md) | [570](/filings/0000931148-25-000156.md) | [485](/filings/0000931148-26-000087.md) | [466](/filings/0000931148-26-000051.md) | [517](/filings/0000931148-26-000073.md) | [519](/filings/0000931148-26-000087.md) |
| Total assets | $m | [1,289](/filings/0000931148-25-000028.md) | [1,216](/filings/0000931148-24-000065.md) | [1,163](/filings/0000931148-24-000101.md) | [1,143](/filings/0000931148-24-000121.md) | [1,224](/filings/0000931148-26-000017.md) | [1,208](/filings/0000931148-25-000073.md) | [1,112](/filings/0000931148-25-000117.md) | [1,108](/filings/0000931148-25-000156.md) | [1,029](/filings/0000931148-26-000087.md) | [997](/filings/0000931148-26-000051.md) | [1,043](/filings/0000931148-26-000073.md) | [1,022](/filings/0000931148-26-000087.md) |
| Current liabilities | $m | [191](/filings/0000931148-25-000028.md) | [166](/filings/0000931148-24-000065.md) | [138](/filings/0000931148-24-000101.md) | [147](/filings/0000931148-24-000121.md) | [140](/filings/0000931148-26-000017.md) | [149](/filings/0000931148-25-000073.md) | [114](/filings/0000931148-25-000117.md) | [135](/filings/0000931148-25-000156.md) | [128](/filings/0000931148-26-000087.md) | [140](/filings/0000931148-26-000051.md) | [125](/filings/0000931148-26-000073.md) | [146](/filings/0000931148-26-000087.md) |
| Long-term debt | $m | [926](/filings/0000931148-25-000028.md) | [927](/filings/0000931148-24-000065.md) | [928](/filings/0000931148-24-000101.md) | [929](/filings/0000931148-24-000121.md) | [1,087](/filings/0000931148-26-000017.md) | [1,089](/filings/0000931148-25-000073.md) | [1,091](/filings/0000931148-25-000117.md) | [1,093](/filings/0000931148-25-000156.md) | [1,095](/filings/0000931148-26-000087.md) | [1,097](/filings/0000931148-26-000051.md) | [1,199](/filings/0000931148-26-000073.md) | [1,201](/filings/0000931148-26-000087.md) |
| Current portion of debt | $m | [0.1](/filings/0000931148-25-000028.md) | [0.1](/filings/0000931148-24-000065.md) | [0.1](/filings/0000931148-24-000101.md) | [0.1](/filings/0000931148-24-000121.md) | [0.0](/filings/0000931148-25-000028.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | [0.1](/filings/0000931148-25-000028.md) | not reported | not reported | not reported | [0.0](/filings/0000931148-25-000028.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [78.2](/filings/0000931148-26-000017.md) | [37.6](/filings/0000931148-25-000156.md) | [16.2](/filings/0000931148-25-000156.md) | [(9.0)](/filings/0000931148-25-000156.md) | [(78.9)](/filings/0000931148-26-000087.md) | [(105)](/filings/0000931148-26-000087.md) | [(168)](/filings/0000931148-26-000087.md) | [(194)](/filings/0000931148-26-000087.md) | [(260)](/filings/0000931148-26-000087.md) | [(304)](/filings/0000931148-26-000087.md) | [(346)](/filings/0000931148-26-000087.md) | [(388)](/filings/0000931148-26-000087.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [9.3 d](/filings/0000931148-26-000017.md) | [(0.5)](/filings/0000931148-25-000073.md) | [(36.9) d](/filings/0000931148-25-000117.md) | [23.7 d](/filings/0000931148-25-000156.md) | [(26.4) d](/filings/0000931148-26-000017.md) | [(32.2)](/filings/0000931148-26-000051.md) | [(53.2) d](/filings/0000931148-26-000073.md) | [24.7 d](/filings/0000931148-26-000087.md) | [(20.9) d](/filings/0000931148-26-000017.md) | [(14.9)](/filings/0000931148-26-000051.md) | [(68.6) d](/filings/0000931148-26-000073.md) | [(8.4) d](/filings/0000931148-26-000087.md) |
| Capital expenditure | $m | [5.8 d](/filings/0000931148-26-000017.md) | [10.5](/filings/0000931148-25-000073.md) | [7.0 d](/filings/0000931148-25-000117.md) | [4.0 d](/filings/0000931148-25-000156.md) | [12.8 d](/filings/0000931148-26-000017.md) | [10.3](/filings/0000931148-26-000051.md) | [3.9 d](/filings/0000931148-26-000073.md) | [6.3 d](/filings/0000931148-26-000087.md) | [18.4 d](/filings/0000931148-26-000017.md) | [12.1](/filings/0000931148-26-000051.md) | [6.9 d](/filings/0000931148-26-000073.md) | [7.8 d](/filings/0000931148-26-000087.md) |
| Dividends paid | $m | [0.0 d](/filings/0000931148-26-000017.md) | [0.0](/filings/0000931148-24-000065.md) | [0.0 d](/filings/0000931148-24-000101.md) | [0.0 d](/filings/0000931148-24-000121.md) | [0.0 d](/filings/0000931148-26-000017.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [0.0 d](/filings/0000931148-25-000028.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [257](/filings/0000931148-24-000065.md) | [257](/filings/0000931148-24-000101.md) | [257](/filings/0000931148-24-000121.md) | [257](/filings/0000931148-25-000073.md) | [258](/filings/0000931148-25-000117.md) | [25.8](/filings/0000931148-25-000156.md) | [25.8](/filings/0000931148-26-000051.md) | [25.9](/filings/0000931148-26-000073.md) | [25.9](/filings/0000931148-26-000087.md) | [26.1](/filings/0000931148-26-000051.md) | [26.3](/filings/0000931148-26-000073.md) | [26.5](/filings/0000931148-26-000087.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 26,897,473 at 2026-10-16, from the cover of the [10-Q filed 2026-10-23](/filings/0000931148-26-000087.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.